Last reviewed · How we verify
NCT05902546
Effect of HIIT Vs Moderate Intensity Aerobic Exercise on Insulin Resistance in Type 2 DM
NA trial testing High intensity interval training in Diabetes Mellitus in 80 participants. Completed in 30 September 2023.
31 August 2023
Quick facts
| Lead sponsor | Badr University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 7 January 2023 |
| Primary completion | 31 August 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 4 locations across Egypt |
Drugs / interventions tested
- High intensity interval training
- moderate intensity aerobic exercise
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
- Insulin Resistance — all drugs for Insulin Resistance →
Sponsor
Badr University
Who can join
Adults 30 to 60, any sex, with Diabetes Mellitus or Insulin Resistance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparing between the efficacy of high intensity interval training and moderate intensity aerobic exercises on insulin resistance in type 2 Diabetes Mellitus.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05902546
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of High intensity interval training
Trials testing the same drug.
- NCT07153523 — Effect of High Intensity Interval Training on Strength, Endurance and Flexibility · NA · recruiting
- NCT07328568 — Effect of Low Volume Sprint Interval Training on Cardiorespiratory Fitness · NA · active not recruiting
- NCT07025694 — Exercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study · NA · recruiting
- NCT06509464 — Response Of Metabolic Syndrome Severity Score To High Intenisty Interval Training In Women With Central Obesity. · NA · recruiting
- NCT07046520 — Effects of HIIT on Plasma Volume and Aerobic Capacity in Obese Adolescent Girls · NA · completed
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Badr University trials
Trials by the same sponsor.
- NCT07395895 — Effect of Metformin Iontophoresis on Knee Osteoarthritis in Postmenopausal Women · Phase 3 · not yet recruiting
- NCT07399743 — Effects of Lower Body Positive Pressure Therapy Versus Alpha Lipoic Acid and Omega-3 Fatty Acids on Knee Osteoarthritis · Phase 3 · not yet recruiting
- NCT07272967 — Metformin in Preventing Secondary Gliosis Following Acute Thoraco-Lumbar Spinal Cord Injury · Phase 4 · not yet recruiting
- NCT07296146 — Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients. · Phase 3 · not yet recruiting
- NCT07180745 — Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05902546 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Badr University
- Last refreshed: 27 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05902546.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing